Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Association of HLA-G Haplotype Risk Model with Treatment Free Survival In Chronic Lymphocytic Leukemia Patients

Johanna Kapp, Crista Ochsenfarth, Magdalena Switala, Ulrich Frey, MD, Ludger Sellmann, MD, Jan Duerig, MD, Peter A Horn, MD, Ulrich Duehrsen, MD, Vera Rebmann, PhD, Holger Nuckel, MD

Blood (2010) 116 (21): 2418.

https://doi.org/10.1182/blood.V116.21.2418.2418

Published: 2010

Journal Articles

Expanded CLL CD8 + T-Cells Are Driven Into a Senescent KLRG1 + Effector Memory Phenotype

Joachim Rudolf Göthert, MD, Lewin Eisele, MD, Ludger Klein-Hitpass, Stefanie Weber, Anja Führer, Ludger Sellmann, MD, Alexander Roeth, MD, Ulrich Duehrsen, MD, Hanspeter Pircher, Jan Dürig

Blood (2010) 116 (21): 913.

https://doi.org/10.1182/blood.V116.21.913.913

Published: 2010

Journal Articles

A New MicroRNA Risk Model for Prediction of Clinical Outcome In Chronic Lymphocytic Leukemia

Holger Nuckel, MD, Crista Ochsenfarth, Ludger Sellmann, MD, Jan Duerig, MD, Ulrich Duehrsen, MD, Ulrich Frey, MD

Blood (2010) 116 (21): 3592.

https://doi.org/10.1182/blood.V116.21.3592.3592

Published: 2010

Journal Articles

Gene Dosage Effects in B-Chronic Lymphocytic Leukemia with Del 13q14.

Ludger Sellmann, MD, Rene Scholtysik, Holger Nueckel, MD, Tanja Boes, Alexander Carpinteiro, MD, Ulrich Duehrsen, MD, Ludger Klein-Hitpass, Jan Duerig, MD, Ralf Kueppers

Blood (2009) 114 (22): 2640.

https://doi.org/10.1182/blood.V114.22.2640.2640

Published: 2009

Journal Articles

Abnormal Free Light Chain Ratios in Chronic Lymphocytic Leukemia: A New Prognostic Factor?.

Johannes Matschke, MD, Lewin Eisele, MD, Ludger Sellmann, MD, Ulrich Duehrsen, MD, Jan Duerig, MD, Holger Nückel, MD

Blood (2009) 114 (22): 1237.

https://doi.org/10.1182/blood.V114.22.1237.1237

Published: 2009

Journal Articles

Shorter Telomeres Are Associated with the Unfavourable Chromosomal Aberrations Del 17p and Del 11q in Chronic Lymphocytic Leukemia (CLL)

Ludger Sellmann, MD, Dirk de Beer, Marius Bartels, Holger Nueckel, MD, Ulrich Duehrsen, MD, Jan Duerig, MD, Gabriela Baerlocher, MD, Alexander Roeth, MD

Blood (2008) 112 (11): 3131.

https://doi.org/10.1182/blood.V112.11.3131.3131

Published: 2008

Journal Articles

Inversely Association of the Aiolos Transcription Factor with Clinical Progression in Chronic Lymphocytic Leukemia.

Holger Nückel, MD, Ulrich H Frey, MD, Ludger Sellmann, MD, Crista H Collins, Ulrich Duehrsen, MD, Winfried Siffert, MD

Blood (2008) 112 (11): 2069.

https://doi.org/10.1182/blood.V112.11.2069.2069

Published: 2008

Journal Articles

Significantly Shorter Telomeres in T-Cells of ZAP-70 + /CD38 + Patients with Chronic Lymphocytic Leukemia (CLL): An Important Role of T-Cells in This Subgroup of CLL?.

Alexander Roeth, MD, Dirk de Beer, Holger Nueckel, MD, Ludger Sellmann, MD, Ulrich Duehrsen, MD, Jan Duerig, MD, Gabriela M. Baerlocher, MD

Blood (2007) 110 (11): 1120.

https://doi.org/10.1182/blood.V110.11.1120.1120

Published: 2007

Journal Articles

Gene Expression Signatures Separate B-Cell Chronic Lymphocytic Leukemia Prognostic Subgroups Defined by ZAP-70 and CD38 Expression Status.

Jan Dürig, MD, Andreas Hüttmann, MD, Ludger Klein-Hitpass, PhD, Ludger Sellmann, MD, Ulrich Dührsen, MD

Blood (2006) 108 (11): 4954.

https://doi.org/10.1182/blood.V108.11.4954.4954

Published: 2006

Journal Articles

Association of a novel regulatory polymorphism (−938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia

Holger Nückel, Ulrich H. Frey, Maja Bau, Ludger Sellmann, Jens Stanelle, Jan Dürig, Karl-Heinz Jöckel, Ulrich Dührsen, Winfried Siffert

Blood (2006) 109 (1): 290–297.

https://doi.org/10.1182/blood-2006-03-007567

Published: 2006

Journal Articles

Association of a Novel Regulatory Polymorphism (-938C>A) in the BCL2 Gene with Disease Progression in Chronic Lymphocytic Leukemia.

Holger Nueckel, MD, Ulrich H. Frey, MD, Ludger Sellmann, MD, Jan Duerig, MD, Ulrich Duehrsen, Winfried Siffert

Blood (2005) 106 (11): 2105.

https://doi.org/10.1182/blood.V106.11.2105.2105

Published: 2005

NARROW

Association of HLA-G Haplotype Risk Model with Treatment Free Survival In Chronic Lymphocytic Leukemia Patients

Expanded CLL CD8 + T-Cells Are Driven Into a Senescent KLRG1 + Effector Memory Phenotype

A New MicroRNA Risk Model for Prediction of Clinical Outcome In Chronic Lymphocytic Leukemia

Gene Dosage Effects in B-Chronic Lymphocytic Leukemia with Del 13q14.

Abnormal Free Light Chain Ratios in Chronic Lymphocytic Leukemia: A New Prognostic Factor?.

Shorter Telomeres Are Associated with the Unfavourable Chromosomal Aberrations Del 17p and Del 11q in Chronic Lymphocytic Leukemia (CLL)

Inversely Association of the Aiolos Transcription Factor with Clinical Progression in Chronic Lymphocytic Leukemia.

Significantly Shorter Telomeres in T-Cells of ZAP-70 + /CD38 + Patients with Chronic Lymphocytic Leukemia (CLL): An Important Role of T-Cells in This Subgroup of CLL?.

Gene Expression Signatures Separate B-Cell Chronic Lymphocytic Leukemia Prognostic Subgroups Defined by ZAP-70 and CD38 Expression Status.

Association of a novel regulatory polymorphism (−938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia

Association of a Novel Regulatory Polymorphism (-938C>A) in the BCL2 Gene with Disease Progression in Chronic Lymphocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only